Background-Although much is known about the risk factors for poor outcome in patients hospitalized with acute heart failure and left ventricular dysfunction, much less is known about the syndrome of acute heart failure primarily affecting the right ventricle (acute right heart failure). Methods and Results-By using Stanford Hospital's pulmonary hypertension database, we identified consecutive acute right heart failure hospitalizations in patients with PAH. We used longitudinal regression analysis with the generalized estimating equations method to identify factors associated with an increased likelihood of 90-day mortality or urgent transplantation. From June 1999 to September 2009, 119 patients with PAH were hospitalized for acute right heart failure (207 episodes). Death or urgent transplantation occurred in 34 patients by 90 days of admission. Multivariable analysis identified a higher respiratory rate on admission (Ͼ20 breaths per minute; OR, 3.4; 95% CI, 1.5-7.8), renal dysfunction on admission (glomerular filtration rate Ͻ45 mL/min per 1.73 m 2 ; OR, 2.7; 95% CI, 1.2-6.3), hyponatremia (serum sodium Յ136 mEq/L; OR, 3.6; 95% CI, 1.7-7.9), and tricuspid regurgitation severity (OR, 2.5 per grade; 95% CI, 1.2-5.5) as independent factors associated with an increased likelihood of death or urgent transplantation. Conclusions-These results highlight the high mortality after hospitalizations for acute right heart failure in patients with PAH. Factors identifiable within hours of hospitalization may help predict the likelihood of death or the need for urgent transplantation in patients with PAH. (Circ Heart Fail. 2011;4:692-699.)
P ulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling and often leads to progressive right ventricular failure. Despite recent advances in therapy, the 5-year mortality of patients with PAH remains as high as 40%. 1 
Clinical Perspective on p 699
As the disease progresses, patients with PAH are often hospitalized with acute right heart failure. Although much is known about the characteristics and predictors of short-term outcome in patients with acute left heart failure, much less is known about the syndrome of acute right heart failure. [2] [3] [4] [5] [6] [7] In patients with acute left heart failure, large observational studies have identified hypotension on admission, renal dysfunction, hyponatremia, anemia, and the presence of coronary artery disease as predictors of short-term mortality. [2] [3] [4] [5] In a recent study of patients with PAH hospitalized with acute heart failure in the intensive care unit, Sztrymf and colleagues 8 found that serum levels of creatinine, B-type natriuretic peptide, and C-reactive protein were significantly higher in nonsurvivors (nϭ19) when compared with survivors (nϭ27).
In the current study, we sought to determine whether characteristics identifiable at hospitalization for acute right heart failure, including echocardiographic parameters, are associated with a higher likelihood of death or transplantation. We hypothesized that renal dysfunction on admission, hyponatremia, and markers of right ventricular dysfunction would be strongly associated with poor short-term outcome in patients with PAH hospitalized with acute right heart failure. [2] [3] [4] [5] 9, 10 
Methods

Study Design
After approval by the institutional review board, patients Ͼ18 years with a confirmed diagnosis of World Health Organization group 1 pulmonary hypertension (PAH) were screened for inclusion in the study. The diagnosis of PAH was based on the standard definition of a mean pulmonary arterial pressure Ͼ25 mm Hg and a pulmonary artery wedge pressure Յ15 mm Hg on diagnostic right heart catheterization. 1, 11 Patients with a diagnosis of portopulmonary hypertension were excluded from the study because of the potential confounding effects of liver disease. Other exclusion criteria were pulmonary hypertension associated with left heart disease, interstitial lung disease, thromboembolic pulmonary hypertension, and sarcoidosis.
Acute right heart failure was defined as new-onset or rapidly worsening heart failure requiring urgent inpatient therapy. 12 To be considered an acute right heart failure episode, evidence of volume overload or low cardiac output syndrome requiring intravenous diuretic therapy or vasopressor therapy had to be present. We excluded hospitalizations for acute exacerbation of right-sided heart failure at facilities other than Stanford Hospital and hospitalizations for patients admitted for hospice care. Planned hospitalizations for the initiation of intravenous prostanoid therapy were also excluded from the analysis.
Two physicians (T.P. and E.F.) trained in data extraction and blinded to study hypothesis extracted data from the pulmonary hypertension database and Stanford Hospital's electronic medical records. Stanford's pulmonary hypertension database is an ongoing observational pulmonary hypertension database. Patients are routinely observed at the adult pulmonary hypertension clinic at least at 3-to 6-month intervals or earlier, depending on the severity of disease and clinical worsening. As of September 2009, the pulmonary hypertension database contained clinical information on 495 patients with pulmonary hypertension, many observed for Ͼ5 years. Figure 1 summarizes the steps for selection of the study population.
Of the 261 patients diagnosed as having PAH, 43 were excluded for the following reasons: 30 were diagnosed as having portopulmonary hypertension, 3 had complex congenital heart disease (ie, polysplenia heterotaxia syndrome [2 patients] and Shone complex [1 patient]), and 10 had evidence of significant left heart disease (left ventricular ejection fraction Յ40%) or significant pulmonary interstitial disease. Of the 218 patients with PAH considered for the study, 119 were hospitalized with acute right heart failure. A total of 189 hospitalizations had complete clinical, echocardiographic, and outcome data available (final data set). Eighteen hospitalizations were excluded for incomplete data retrieval (8.6% of hospitalizations). The hospitalizations excluded consisted of repeat hospitalizations and were not associated with mortality or urgent transplantation within 90 days of admission. In patients with multiple hospitalizations within a 3-month period (nϭ8), the longest hospitalization was considered the index hospitalization.
Combined End Point
The primary end point consisted of mortality or lung transplantation within 90 days of hospitalization. Death was verified through the National Social Security Death Index, and transplantation was verified through medical record review.
Data Collection
For each acute right heart failure hospitalization, data collection included New York Heart Association functional class, admission values for vital signs, laboratory data, and echocardiographic data. Admission laboratory data consisted of serum creatinine, blood urea nitrogen, serum total carbon dioxide, serum sodium, total bilirubin, serum albumin, hemoglobin, and N terminal B-type natriuretic peptide (NT-pro-BNP). NT-pro-BNP serum levels when available (nϭ84). Levels of NT-pro-BNP were ordered in most patients (88%) hospitalized from January 2005 to September 2009. The glomerular filtration rate (GFR) on admission to the hospital was estimated using the simplified Modification of Diet in Renal Disease studyderived equations. 13 For right heart catheterization values, the cardiac index was calculated using the Fick method, with oxygen consumption estimated from the La Farge table, per our clinical practice. 14 
Echocardiography
Digitized echocardiographic studies were analyzed by a reader (F.H.) blinded to clinical outcomes using quantitative criteria, in accordance with the published guidelines of the American Society of Echocardiography. 15, 16 Echocardiographic studies were obtained within 48 hours of admission in 94% of cases and within 2 weeks for the remainder of the studies.
Right ventricular systolic pressure was estimated using the maximal modal velocity of the tricuspid regurgitation (TR) Doppler signal. 16 The right atrial pressure (RAP) was estimated using the size and collapse index of the inferior vena cava (IVC). The RAP was estimated to be 5 mm Hg if the size of the IVC was Ͻ2 cm and the collapse index was Ͼ50%; 10 mm Hg if either the size of the IVC was Ͼ2 cm or the collapse index was Ͻ50% but Ͼ10%; 15 mm Hg if both the size of the IVC was Ͼ2 cm and the collapse index was Ͻ50% but Ͼ10%; and 20 mm Hg if the size of the IVC was Ͼ2 cm and the collapse index was Ͻ10%. 15, 17 The right ventricular end-diastolic area and the right atrial maximal area were quantified from the apical 4-chamber view and indexed to body surface area. The right ventricular function was quantified using the following 3 indexes: right ventricular fractional area change (RVFAC), tricuspid annular plane systolic excursion (TAPSE), and RV myocardial performance index, as previously described. 15, 18 The eccentricity index was calculated as the ratio of left ventricular internal diameter parallel to the septum/left ventricular internal diameter perpendicular to the septum in the parasternal short axis view. Right ventricular and right atrial sizes are reported as relative right/left chamber size ratio. Tricuspid regurgitation was considered severe in the presence of at least 2 of these criteria: (1) vena contracta width Ͼ0.7 cm, (2) jet area Ͼ10 cm 2 for central jets at a Nyquist limit of 50 to 60 cm/s with a relative jet to atrial size Ͼ40%, or (3) systolic reversal in the hepatic veins. 16 Mild TR was diagnosed if the jet area was Ͻ5 cm 2 for central jets at a Nyquist limit of 50 to 60 cm/s with a systolic dominance of hepatic vein flow. Moderate TR was diagnosed if criteria of severe or mild TR were not met. 16 Figure 1 . Study population. A total of 261 patients diagnosed as having PAH were screened for inclusion in the study, of whom 119 were hospitalized for acute right heart failure (ARHF) (nϭ207). Complete clinical characterization was available for 189 hospitalizations.
Statistical Analysis
Results are expressed as meanϮSD for continuous variables or as number of cases and percentages for categorical variables for the final cohort of 189 hospitalizations. We used longitudinal regression models with the generalized estimating equations method to identify potential factors associated with an increased likelihood of 90-day mortality or urgent transplantation (PASW 18.0 Inc; Chicago, IL). The generalized estimating equations model was chosen as the primary statistical method of analysis instead of the Cox proportional hazard models to better account for the longitudinal study design and clustering of the data associated with repeated hospitalizations. 19 The results of the multivariable Cox proportional hazard model are also presented. Each hospitalization entered in the statistical model had complete clinical data, and right censoring was not required.
Stepwise regression analysis was performed to identify independent factors associated with poor outcome. For the regression analysis, variables with PՅ0.2 were sequentially entered into the model; after entering the model, variables were removed if PϾ0.3. Variable selection for the multivariable model was guided by both clinical and statistical significance. Because of the expected few events and the absence of the validation cohort, the model presented should only be viewed as exploratory. Thresholds for categorical variables were based on the values associated with the highest average of sensitivity and specificity on receiver operating characteristic curve analysis for the event of death or transplantation within 90 days. A predefined subgroup analysis of consecutive hospitalizations for which NT-BNP levels were available was also conducted. PϽ0.05 was considered statistically significant in the univariate and multivariable analyses. The intraobserver variability for indexes of RV function was calculated using absolute differences between estimations and the intraclass correlation coefficient (ICC). 20 An ICC value between 0.5 and 0.6 indicates moderate agreement; an ICC value between 0.7 and 0.8, strong agreement; and an ICC value Ͼ0.8, very strong agreement.
Intraobserver Variability in Measurements of RV Indexes
To determine intraobserver variability, a single blinded reader (F.H.) repeated the measurements on 50 studies within a 3-month period. There was good concordance between measures of RV parameters performed at 3-month intervals of each other. For RVFAC, the average difference in absolute measurement was 4Ϯ3%, with an ICC of 0.87; for TAPSE, the average difference in absolute measurement was 0.1Ϯ0.1 cm, with an ICC of 0.93; and for RV myocardial performance index, the average difference in absolute measurement was 0.09Ϯ0.06, with an ICC of 0.94. For estimation of right ventricular systolic pressure, the average difference in absolute measurement was 3Ϯ2 mm Hg, with an ICC of 0.88. All studies were read by a single reader (F.H.) for consistency. The reader interprets, on average, 3000 echocardiographic studies yearly in the echocardiographic laboratory at Stanford Hospital. When compared with the official reports, agreement on TR severity was noted in 94% of cases. Table 2 summarizes the characteristics of patients hospitalized with acute right heart failure. Most patients were symptomatic at rest (New York Heart Association functional class IV on admission [68%]), whereas the others were symptomatic, with minimal exertion (New York Heart Association functional class IIIb) or had severe right-sided congestive symptoms. Forty-six percent of the patients were on intravenous prostanoid therapy on their first admission and 75% were initiated on prostanoid therapy during their followup. The median length of in-hospital stay was 6 days (range, 2-96 days). Inotropic support was required in 33 hospitalizations (17%) ( Figure 2 ). The number of acute right heart failure hospitalization per patient was 1.7Ϯ0.9 (range, 1-6), with 70 patients requiring rehospitalization for acute heart failure.
Results
Population and Baseline Characteristics
Characteristics of Acute Right Heart Failure Hospitalizations
Hypotension on admission (systolic blood pressure Ͻ90 mm Hg) occurred in 8.9% of hospitalizations. Tachycardia on admission (heart rate Ͼ100 beats/min) was observed in 24% of hospitalizations. A decrease in GFR to Ͻ45 mL/min per 1.73 m 2 occurred in 21% of cases. An Data are given as meanϮSD unless otherwise indicated. MPAP, mean pulmonary arterial pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; PVRI, indexed pulmonary vascular resistance; RHC, right heart catheterization. Baseline RHC results were obtained within 6 months of the initial outpatient clinic visit.
*Data are given as number (percentage).
elevation in total serum bilirubin Ͼ25.7 mol/L was noted in 20% of episodes, and elevations in alanine aminotransferase Ͼ3 times the upper limits of normal were rare (2% of admissions). Albumin values Ͻ30 g/L were noted in 19% of hospitalizations. Anemia, defined by a hemoglobin level Ͻ120 g/L for women and Ͻ130 g/L for men, was documented on 28% of admissions; total carbon dioxide Ͻ23 mEq/L was observed in 35% of admissions. Echocardiographic data are summarized in Table 2 . Almost half of patients had severe RV systolic dysfunction based on fractional area change criteria (RVFAC Ͻ18%), and 44% of patients had severe TR ( Table 2 ).
Management of Acute Heart Failure Hospitalizations
Diuretics were used in most hospitalizations (96%), and inotropic or vasopressor support was used in 33 hospitalizations (17%). Dobutamine was the preferred inotropic agent (used in 25 cases) and usually initiated at doses of 2.5 g/kg per minute and titrated up to usual doses of 5 to 10 g/kg per minute in the presence of persistent low cardiac output signs (eg, altered mentation or oliguria). Milrinone was used in 6 cases (usual maintenance dose, 0.375 g/kg per minute), and dopamine infusion was used in 2 cases. None of the patients were discharged home with inotropic infusion. Mechanical ventilation for respiratory or circulatory failure was required in 10 episodes (5.3%). Dialysis was initiated in 4 patients.
Of 14 episodes of supraventricular tachycardia, 11 (79%) required either electric (nϭ4) or chemical (nϭ7) cardioversion because of hemodynamic instability. Amiodarone was the most commonly used agent for chemical cardioversion (nϭ6), whereas dofetilide was used in 1 patient.
Primary Combined Outcome
The primary outcome of death or urgent transplantation occurred in 34 patients (168% of hospitalizations) within 90 days of admission (30 deaths and 4 urgent lung transplantations). In hospitalizations requiring inotropic support (nϭ32), the primary outcome occurred in 12 cases (38% of hospitalizations).
The primary outcome occurred within 7 days in 6 patients (18%), between 8 and 30 days in 16 patients (47%), and between 12 and 90 days in 12 patients (35%). In-hospital death occurred in 17 patients (50% of events). Sudden cardiac death was a common mechanism of in-hospital death, occurring in 10 patients; pulseless electric activity occurred in 6 patients, asystole in 3 patients, and ventricular tachycardia in 1 patient. Circulatory failure accounted for the remainder of in-hospital deaths (nϭ7), with 4 patients dying of cardiogenic shock and 3 dying of mixed cardiogenic and septic shock. In the patients dying of circulatory failure, pulseless electric activity and asystole were the final rhythms noted at death. Thirteen patients died in the early postdischarge period (38% of events). The mechanism of death for patients dying in the early postdischarge period (outside the hospital) was not available. Four patients (12%) remained hospitalized, receiving inotropic therapy and awaiting lung transplantation.
Factors Associated With 90-Day Mortality or Urgent Transplantation
Univariate Analysis
We evaluated the association between clinical, laboratory, and echocardiographic parameters and the outcome of 90-day death or urgent transplantation (Table 3 ). To account for baseline severity of pulmonary vascular disease, we included †Anemia is defined by a hemoglobin level Ͻ12 g/dL for women and Ͻ13 g/dL for men. the most recent indexed pulmonary vascular resistance as a covariate in the model. Table 3 summarizes the results of the univariate analysis. The strongest associations were found with age, connective tissue disease cause, respiratory rate, renal dysfunction, serum sodium level, serum albumin level, hemoglobin level, TR, and systolic eccentricity index. Factors not significantly associated with outcome on univariate analysis included blood pressure on admission, heart rate, echocardiographically determined RV size, right atrial size, estimated RAP, and the indexed pulmonary vascular resistance by right heart catheterization.
Threshold Predictive Values for Continuous Variables
Threshold values for univariate parameters associated with outcome were chosen based on the highest sensitivity and specificity of receiver operating characteristic curve analysis ( Table 4 ). The analysis was performed for the most significant continuous variables on univariable analysis (ie, respiratory rate, estimated GFR, serum sodium level, serum albumin level, hemoglobin level, and TAPSE).
Multivariable Analysis
The variables included in the model consisted of age, connective tissue disease cause, estimated GFR, serum sodium level, serum albumin level, hemoglobin level, estimated RAP, TAPSE, and TR severity. The choice of variables was guided by both clinical and statistical significance. For example, TAPSE was included in the model instead of RVFAC because of its increased reproducibility in clinical practice. We limited the number of variables entered in the exploratory model to minimize overfitting of the model. On multivariable analysis, 4 variables were independently associated with outcome, all on admission (ie, respiratory rate, estimated GFR, serum sodium level, and albumin level; Table 5 ). The odds ratios presented in the multivariable model were adjusted for age. Similar results were found with Cox proportional hazard modeling. The hazard ratios associated with the Cox proportional hazard modeling were as follows: respiratory rate Ͼ20 breaths per minute, 2.90 (95% CI, 1.47-5.74); estimated GFR, Յ45 L/min per 1.73 m 2 , 2.73 (95% CI, 1.38 -5.41); serum sodium level Յ136 mEq/L, 3.34 (95% CI, 1.64 -6.81); and TR per grade of regurgitation, 2.08 (95% CI, 1.19 -3.61). With 4 variables retained in the multivariable model, the model may still be overfitted and the results should be viewed as exploratory.
Subgroup Analysis of Hospitalizations for Which NT-BNP Levels Were Available
Levels of NT-pro-BNP were available in 84 hospitalizations. The NT-pro-BNP value was 3480Ϯ4564 pg/mL (25-75% percentile, 881-3778 pg/mL). The NT-pro-BNP levels were normally distributed (a normal distribution was verified using histograms and Kolmogorov-Smirnov tests). On univariate analysis, the odds ratio for NT-pro-BNP per 1000 U was 1.19 (95% CI, 1.06 -1.34). In the same subgroup analysis, the odds ratios were as follows: estimated GFR per 10-U decrease, 1.48 (95% CI, 1.03-2.04); serum sodium level per 5-U decrease, 3.05 (95% CI, 1.61-5.77); respiratory rate per 5-U increase, 2.28 (95% CI, 0.91-5.87); and TR per grade of severity, 2.97 (95% CI, 0.91-9.71). In this subgroup analysis, multivariable analysis was not performed because of the few events.
Discussion
Acute right heart failure represents a major cause of mortality in patients with PAH. In a recent study by Sztrymf and colleagues, patients with PAH hospitalized for acute heart failure in the intensive care unit had a high mortality rate of 42%. 7, 8 In this study, we expand on the experience of Sztrymf and colleagues 8 and describe the characteristics of patients hospitalized in both the intensive and nonintensive care setting. Consistent with their findings, we found that acute right heart failure in patients with pulmonary hypertension is associated with a significant burden of disease, with 17% of patients requiring a coronary care unit level of care and a 90-day mortality rate of 16%. In patients hospitalized in the coronary care unit, the mortality or urgent transplantation rate was as high as 38% by 90 days.
Compared with patients with acute left heart failure, patients with PAH are younger, are more often women, and have a higher prevalence of connective tissue disease and congenital heart disease. 4 Comorbid conditions, such as systemic hypertension, diabetes mellitus, or peripheral vascular disease, were also less common in our patient cohort. Despite their younger age, the mortality rate observed in patients with acute right heart failure was comparable to those observed in patients with acute heart failure and left ventricular dysfunction. 2, 4, 5 As in patients with left heart failure, most deaths occurred either in the hospital or early after discharge. The early postdischarge period appears to be particularly vulnerable for patients because they may continue to deteriorate. In patients with left heart failure, studies have confirmed deterioration in the neurohormonal profile and renal function during the first few weeks after discharge in patients who die or were rehospitalized. 4 Both circulatory failure and sudden cardiac death may contribute to the mortality of patients with acute right heart failure syndrome. As has been previously shown, sudden cardiac death in patients with PAH often occurs as a result of bradycardia, asystole, or pulseless electric activity. 21 Identifying predictors of poor outcome may help guide in-hospital care and postdischarge management. In this study, we found that several characteristics available within the first few hours of hospital presentation were strongly associated with short-term mortality or urgent transplantation. Among them, higher respiratory rate on admission, renal dysfunction, hyponatremia, and TR severity appear to be more strongly related to outcome.
Higher respiratory rate on admission was strongly associated with outcome and may be a marker of ventilatory inefficiency, increased systemic oxygen demands, or increased respiratory drive in response to metabolic acidosis. In the long-term setting, several studies 22, 23 have shown that ventilator inefficiency, measured by the ratio of minute ventilation/rate of carbon dioxide elimination, is associated with decreased survival in patients with PAH. Ventilatory inefficiency in patients with PAH may be caused by ventilation-perfusion mismatches, low cardiac output, or increased ventilatory drive. 22, 23 Future studies will be needed to examine the importance of ventilatory inefficiency in the setting of acute right heart failure.
Renal dysfunction and hyponatremia are emerging as strong predictors of outcome in PAH. 10 Shah and colleagues 10 have previously demonstrated that elevated serum creatinine at the initial PAH clinic visit independently predicted mortality. In a study by Forfia and colleagues, 9 hyponatremia was independently associated with poor long-term survival in PAH. The prognostic value of serum creatinine and hyponatremia has also been previously well validated in patients hospitalized with acute left heart failure. Both decreased renal perfusion and increased congestion may contribute to the cardiorenal syndrome. 24, 25 Hyponatremia may also be a strong marker of altered renin-angiotensin-aldosterone homeostasis. 9 We have also found that TR is a marker of a failing right ventricle. Tricuspid regurgitation usually occurs in the setting of annular tricuspid dilatation or altered ventricular or tricus- *The criterion value presented had the optimal balanced sensitivity and specificity for predicting death or transplantation at 90 days after admission. Only candidate variables that were associated with the primary outcome on univariate analysis (PՅ0.2) were entered as potential covariates in the multivariable logistic regression model. Odds ratios were adjusted for age in the multivariable modeling. pid valve geometry. 26 Tricuspid regurgitation was a factor more strongly associated with outcome than RAP, right ventricular systolic pressure, or quantitative measures of RV size or function. This may be partially explained by the fact that most patients with PAH hospitalized for acute right heart failure have moderate to severe systolic dysfunction. Furthermore, TAPSE or RVFAC may not adequately reflect ventricular dysfunction in patients with severe TR. Previous studies 27, 28 have also emphasized the predictive value of TR in PAH and cardiovascular disease.
In our subgroup analysis, NT-pro-BNP also emerged as a factor associated with outcome. This finding is consistent with the findings of the study of Sztrymf and colleagues, 8 who found that BNP was significantly higher in nonsurvivors when compared with survivors. B-type natriuretic peptide and NT-pro-BNP have also predicted long-term survival in PAH. 29, 30 Future studies are needed to determine whether NT-BNP will have incremental value to chronic kidney disease or hyponatremia in the setting of acute right heart failure. Our study also indicates other candidate predictors of outcomes that will require further validation in a large multicenter study. Possible candidate variables found on univariable analysis include connective tissue disease cause, anemia, and low serum albumin levels.
Our study has 2 major clinical implications. First, identifying predictors of poor outcome may help guide in-hospital care. For example, patients with evidence of low cardiac output or renal dysfunction may benefit from closer monitoring in the intensive care unit and initiation of tailored inotropic or prostanoid therapy or early referral for lung transplantation. Further studies are needed to determine the best management strategy of patients with acute right heart failure. In the study by Sztrymf and colleagues, 8 the use of intravenous prostacyclin in the intensive care unit was not associated with survival benefit, although, as the authors discuss, in the absence of randomization, it is difficult to interpret the effects of pH-specific therapies. Based on experimental studies, intravenous epoprostenol improves right ventricular-pulmonary arterial coupling and could, therefore, be theoretically beneficial in acute right heart failure in the absence of severe hypotension. 31 Second, patients should be observed early after a hospitalization for acute right heart failure because this represents a highly vulnerable period. Patients showing signs of decline in their functional status would probably benefit from readmission and optimization of their therapy.
This study has limitations that have to be acknowledged. The study was mainly limited by the single-center study design and fewer events. The few events limits the number of variables that can be entered into the multivariable model and our ability to cross-validate our findings in an independent series. 32 Our findings provide, however, external validation of key findings of the study by Sztrymf and colleagues. 8 Finally, it is important to recognize that with increasing experience in managing acute right heart failure and closer postdischarge follow-up, the mortality rate is also likely to be lower in more contemporary series.
Conclusion
Admission for acute right heart failure in patients with PAH is associated with a significant risk of mortality or urgent transplantation. An increased respiratory rate on admission, renal dysfunction, hyponatremia, and severe TR are associated with poor short-term outcome. Future large multicenter prospective studies are needed to validate these findings and to develop predictive models in acute right heart failure syndrome. Identifying novel treatment strategies in patients with PAH and acute heart failure will also be essential to improve outcome.
